autologous immunoregulatory dendritic cells
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2015 (NCT02354911)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous immunoregulatory dendritic cells
- idc
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02354911 | Phase 2 | Oct 1, 2015 | Allegheny Health Network, DiaVacs, Inc., Stanford University, University of Miami, University of Pittsburgh |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Allegheny Health Network | Academic/Hospital | 1 | 0 | 1 | 2015 |
| DiaVacs, Inc. | For profit | 1 | 1 | 1 | 2015 |
| Stanford University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Miami | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2015 |
5 organizations
Page 1 / 1